Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

RMJ. 2013; 38(1): 26-31


Fulminant variants of multiple sclerosis – local experience at Shifa International Hospital, Islamabad, Pakistan

Arsalan Ahmad, Nadia Mehboob, Ismail Abdul Latif Khatri, Maimoona Siddiqui, Javeria Khizar, Maryam Jameel.

Abstract
Background:
Fulminant variants of multiple sclerosis (MS) are usually monophasic illnesses that lead to rapid and continuous progression of disabilities. Very high mortality and morbidity has been reported with these variants however in our series patients treated aggressively with immunotherapy have shown complete or near complete recovery.

Methods:
We report a case series of 4 patients with fulminant variants of MS seen between January 2008 and February 2011 at Shifa International Hospital, Islamabad. Data was collected retrospectively through chart review, and follow up information was obtained from clinic visits.

Results:
Four patients, three females, with mean age of 27(range 13-40) years. Onset was acute with significant progression over 2 weeks in all cases. Pertinent presenting symptoms were hemiparesis and speech difficulty in all 4 patients, 3 had visual impairment, and 2 had headache. CSF pleocytosis and raised CSF protein was seen in 3 patients each. Visual evoked potentials were abnormal in one patient. Based on the characteristic MRI findings, 3 patients were diagnosed as Balo’s concentric sclerosis and one patient with Marburg’s variant of MS. All patients were initially treated with intravenous methylprednisolone followed by immunomodulatory therapy. Two patients received intravenous immunoglobulins (IVIG) and mitoxantrone, one received IVIG only and one received mitoxantrone only. On follow up, all 4 patients had shown marked improvement with independence in activities of daily living.

Conclusion:
Aggressive treatment with IVIG and mitoxantrone resulted in significant improvement in this small case series. Early and aggressive immunosuppression should be considered in patients with fulminant variants of MS.

Key words: Fulminant, variants, multiple sclerosis, outcomes, Pakistan



Share this Article


Advertisement
Journal of Interdisciplinary Histopathology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.